Close menu




BAYER AG NA O.N.

Photo credits: pixabay.com

Commented by André Will-Laudien on October 13th, 2020 | 13:34 CEST

Bayer, Barrick, Desert Gold: In Gold we trust!

  • Gold

The global economy moving at different speeds. In the USA, the ISM index for services is once again expanding slightly. In China, the mood in the service industry is once again pointing to a veritable recovery. In the eurozone, the economic sentiment examined by the analyst firm, Sentix, remains robust but without any new highs. Even with the rising infection rate, the pandemic will come to an end eventually. In Germany, economic data such as industrial orders, production, and exports, showed a slight slowdown in August. Nevertheless, the stock markets are swinging to new heights daily, as the latent threat from the infection necessitates further liquidity packages from governments. This monetary policy continues to imply very low-interest rates, a weakening USD, and rising inflation expectations. This environment should keep the demand for precious metals at least at a high level, so we remain on the lookout.

Read

Commented by Mario Hose on September 29th, 2020 | 10:51 CEST

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

  • Health

Investors' expectations of developments can drive the share price. When it comes to solving a problem or creating needs, the interest of the capital market is particularly high. Things get exciting for investors when the business model offers the possibilities of scalability. Attractive investment opportunities can be created in the fields of health and medicine, which offer extraordinary return opportunities.

Read

Commented by Mario Hose on September 22nd, 2020 | 09:20 CEST

Almonty, BASF, Bayer: where is it worth starting now?

  • Investments

The start of the week was marked by price losses. In Europe and North America, the leading indices closed in the red. The fear of further effects of the Corona Pandemic has dampened market sentiment. Given that the banknote presses are still running, the breather on the capital markets is again likely to be short-lived. At the time when a vaccine against Covid-19 receives approval, the economy will once again experience an unleashed boom - provided that people can and may want to return to their jobs. Which shares are worthwhile now?

Read

Commented by Mario Hose on September 10th, 2020 | 07:37 CEST

Allianz, Bayer, Newlox - Opportunities and risks go hand in hand

  • Gold

If the shares of the U.S. company Apple fluctuate, then the impact on market capitalization may well amount to the entire equivalent value of the fourth-largest DAX company, Allianz. Apple's market value is around EUR 1,640 billion, and against this, Germany's insurance giant, at around EUR 75 billion, looks like a delicate little plant. There are various reasons for this, which lie beyond the objective or fundamental valuation. For one thing, more German investors buy the shares of U.S. companies than the other way around, and moreover, premium smartphones and tablets are simply more exciting for the younger generation of investors than insurance policies. From this perspective, healthy diversification makes perfect sense.

Read

Commented by Mario Hose on August 25th, 2020 | 11:56 CEST

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

  • Investoren

Tuesday began with green lights for most listed companies in Germany. The opinions of analysts and company announcements make the stock prices - or they are driven by the mood of economic data. The Ifo Business Climate Index, for example, rose by 2.2 points to 92.6 points in August 2020 compared to July. The survey data is collected every month from around 9,000 companies and makes it the most important leading indicator in Germany. "The German economy is on course for recovery," Ifo President Clemens Fuest announced. In this context, stocks that still have potential are now exciting.

Read

Commented by Mario Hose on June 8th, 2020 | 11:30 CEST

Aurora, Bayer, XPhyto - scalable growth markets with potential

  • Health

Health is the most precious good in the life of a human being. The preservation and improvement of the quality of life is a large business area. Investors around the globe have the opportunity to participate in many different areas of research and development of products and therapies. The development of new markets and preparations usually requires a lot of risk capital before the fruits can be harvested. At the latest when a scalable solution has been found to improve people's lives, then the value of the company increases.

Read

Commented by Mario Hose on April 20th, 2020 | 09:43 CEST

Bayer, EXMceuticals, Symrise - investing in the healthcare growth market

  • Healthcare

The Corona Pandemic brings with it many changes. The influences in the supply chain are affecting the economy to the point of stagnation. The lack of contact for people creates challenges in coping with everyday life. The term 'home office' is used in an inflationary way - and often misused, because the difference between 'home office' and 'working from home' is the noise and stress level around it. On top of this, there are also supply bottlenecks for hygiene products, basic foodstuffs and protective equipment. According to a recent statement by the Federal Minister of Economics, Peter Altmaier (CDU), Germany will need 12 billion masks per year to protect the population. But the well-being of the people also depends on other factors.

Read

Commented by Mario Hose on March 23rd, 2020 | 15:00 CET

Aurora Cannabis, Bayer, EXMceuticals - ready for the time after Corona

  • Cannabis

The cannabis hype was over and then came the corona crisis. Investors who believed in the active ingredient of cannabis and put money into the shares of companies in this industry are now likely to be sitting on a huge loss in most cases. It all started with the idea of a few companies to make one of the oldest medicinal plants in the world acceptable for general use within the framework of legalization. However, high margins and a large market soon led to competition and a brokerage industry was earning a lot of money - soon several hundred cannabis companies were listed on the stock exchange.

Read

Commented by Mario Hose on November 15th, 2019 | 13:40 CET

BAYER, CONTINENTAL, IWATER GROUP - WHO BENEFITS FROM CLEAN WATER?

  • Water

Water resources around the globe are increasingly polluted by pollutants. The pursuit of prosperity, luxury and safety comes at a price. More people need more food and the yield per hectare must increase through the use of more fertilizers and pesticides. The intake of medicines by humans and animals is also not without its consequences and so drug residues are increasingly becoming a problem. But where there are problems, new business opportunities also arise.

Read